Scienza e Tecnologia

THIRD-QUARTER 2020 SALES

9 THIRD-QUARTER 2020 SALES GOOD RECOVERY WITH SAME-DAY SALES DOWN 4.2%ROBUST PERFORMANCE SUPPORTED BY BEST-IN-CLASS CUSTOMER SERVICE AND DIGITAL OPERATIONS CONTINUED DISCIPLINE ON OPEX AND FOCUS ON CASH FLOW MANAGEMENT→ SALES OF €3,157.8m IN Q3 2020On a constant and same-day basis, sales down 4.2% in Q3 20, recovering sharply from -17.7% in Q2 20. Gradual improvement, with progressive recovery in Europe and Asia-Pacific, while North America is lagging with...
Nasdaq GlobeNewswire
29/10/2020

Pharming Group reports financial results for the first nine months of 2020

Company has initiated the process for a secondary listing in the US on Nasdaq Company has initiated the process for a secondary listing in the US on Nasdaq LEIDEN,Netherlands,Oct. 29, 2020/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) presents its (unaudited) financial report for the nine months and third quarter ended30 September 2020. Financial summary Gross profit Operating profit Net profit 18...
PR Newswire
29/10/2020

Pharming convenes Extraordinary General Meeting of shareholders

In addition, further to the Company announcing today, it has initiated the process for a secondary listing in the US on Nasdaq, the EGM will also address a proposal to amend the Company's articles of association for the implementation of a one-tier Board structure in anticipation of the launch of the Level 2 ADR Programme and the associated Nasdaq listing. The Company has not made any decisions regarding either the timing, or the terms of the Level 2 ADR programme and there can be no certainty…
PR Newswire
29/10/2020

INGENICO GROUP: Third quarter 2020 Q3'20 strongly supports 2020 guidance

Press ReleaseParis, 29 thOctober 2020 Third quarter 2020 Q3'20 strongly supports 2020 guidanceMid to high single digit full year organic decline confirmedAll 2020 objectives reiterated Revenue of €646 million, down 9% on a comparable basis1 Retail growth down 5% in Q3'20, better than expected Activity in SMB, Enterprise and Payone stabilized while Global Online isstill impacted by the Travel verticalB&A performance in the trajectory of a gradual recoverywith a...
Nasdaq GlobeNewswire
29/10/2020

INGENICO GROUP: Governance - Changes to the Board of Directors, to its…

GovernanceChanges to the Board of Directors, to its Committees and to management Paris, October 28, 2020 — The Board of Directors of Ingenico Group met today to acknowledge the change of control of the Company following the successful tender offer initiated by Worldline, as a result of which the latter holds 88.64% of the share capital representing at least 83.20% of voting rights in Ingenico 1and 99.57% of the outstanding OCEANE bonds, before the integration of the shares contributed...
Nasdaq GlobeNewswire
28/10/2020

EKF and Kantaro Partner to Market Quantitative COVID-19 Antibody Testing in the…

NEW YORK, Oct. 28, 2020 /PRNewswire/ -- Kantaro Biosciences, LLC ("Kantaro"), a joint venture between the Mount Sinai Health System and RenalytixAI plc (LSE: RENX / NASDAQ: RNLX), and manufacturing partner Bio-Techne Corporation (NASDAQ: TECH), entered into a two-year marketing and distribution agreement with EKF Diagnostics, a global leader in diagnostic testing. EKF will offer COVID-SeroKlir, Kantaro's quantitative SARS-CoV-2 IgG antibody test kit, in Europe with exclusive rights in…
PR Newswire
28/10/2020

ATM GROUP SECURITE (Delta Drone Group) wins a € 6M contract

ATM GROUP SECURITE (Delta Drone Group) wins a € 6M contract Dardilly, October 28, 2020 ATM Group Securite announces that it has been officially selected by the Ministry of Justice following a public call for tenders relating to the security management of 10 courthouses located in Rhône-Alpes. The contract will start in January 2021 for a 4 years period, corresponding to an overall annual billing of around € 1.5 million excluding tax.Resulting from...
Nasdaq GlobeNewswire
28/10/2020

Bombardier to Report its Third Quarter 2020 Financial Results on November 5…

On November 5, 2020 at 8:00 a.m., EST,Éric Martel, President and Chief Executive Officer; John Di Bert, Senior Vice President and Chief Financial Officer; and Patrick Ghoche, Vice President, Corporate Strategy and Investor Relations, will hold a webcast/conference call intended for investors and financial analysts to review the company's financial results for the third quarter ended September 30, 2020.A live webcast of the call and relevant financial charts will be available at ...
Nasdaq GlobeNewswire
28/10/2020

Ionic Liquids Market To Reach USD 65.8 Million By 2027 | CAGR of 8.8%: Reports…

NEW YORK, Oct. 28, 2020 /PRNewswire/ -- The Global Ionic Liquids Market is projected to reach USD 65.8 million in 2027. The increasing usage of ionic liquids as industrial solvents, especially in the Catalysts and Solvents industry, is driving the market's growth. Apart from this, the need for the development of green chemistry in order to address environmental concerns is predicted to fuel the market's growth during the forecast period. NEW YORK,Oct. 28, 2020/PRNewswire/ -- The Global ...
PR Newswire
28/10/2020

European Commission Grants Marketing Authorization for ARIKAYCE® Liposomal 590…

BRIDGEWATER, N.J., Oct. 28, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that the European Commission (EC) has granted marketing authorization for ARIKAYCE® Liposomal 590 mg Nebuliser Dispersion ("ARIKAYCE") for the treatment of nontuberculous mycobacterial (NTM) lung infections caused by Mycobacterium avium complex (MAC) in adults with limited…
PR Newswire
28/10/2020

Impact Modifiers Market worth $5.0 billion by 2025 - Exclusive Report by…

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=58674504 https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=58674504 Browse in-depth TOC on "Impact Modifiers Market" 189 – Tables 53 – Figures 197 – Pages View Detailed Table of Content Here: https://www.marketsandmarkets.com/Market-Reports/impact-modifier-market-58674504.html The demand for high-quality plastics from various applications increases continuously, which favors the consumption of...
PR Newswire
28/10/2020

Synklino Strengthens Management Team with Key Appointments

COPENHAGEN, Denmark, Oct. 28, 2020 /PRNewswire/ -- Synklino ApS, an emerging biotech company developing first-in-class breakthrough treatment to eliminate cytomegalovirus (CMV) infections in the transplant setting, today announces the appointment of Tolga Hassan as Chief Finance Officer (CFO) and Dr. Josefin-Beate (Josi) Holz as Chief Medical Officer (CMO). This announcement follows the recent closing of a financing round led by Eir Ventures and Vaekstfonden. COPENHAGEN, Denmark,Oct...
PR Newswire
28/10/2020

LBB Specialties Announces Domestic Representation Agreement With Elé Corporation

Jay Lang concludes, "Elé professionals have decades of experience and deep technical expertise, enabling them to turn ideas into reality. By combining research, scale-up, manufacturing and marketing they deliver innovative, quality, cost-effective products. We believe this partnership is an ideal one for Charkit and look forward to distributing their specialty chemical products." Jay Langconcludes, "Elé professionals have decades of experience and deep technical expertise…
PR Newswire
27/10/2020

Incap Corporation: The Finnish Financial Supervisory Authority has approved the…

Incap Corporation Stock exchange release 27 October 2020 at 6.00 p.m. EETNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, SOUTH AFRICA, SINGAPORE, JAPAN, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. The Finnish Financial Supervisory Authority has approved the Finnish-language prospectus related to Incap's rights issue Incap Corporation...
Nasdaq GlobeNewswire
27/10/2020

Human Microbiome Therapeutics Market To Be Worth USD 1,098.4 Million by 2027…

VANCOUVER, BC, Oct. 27, 2020 /PRNewswire/ -- The global Human Microbiome Therapeutics Market is forecast to be worth USD 1,098.4 Million by 2027, according to the latest analysis by Emergen Research. The human microbiome therapeutics market is forecast to augment rapidly due to the rising application of human microbiome therapeutics into personalized medicine and nutrition. Besides, the growing technological advancements in metagenomics and the therapeutic system is anticipated to further propel…
PR Newswire
27/10/2020

Thermal Barrier Coatings Market To Reach USD 25.82 Billion By 2027 | CAGR of…

NEW YORK, Oct. 27, 2020 /PRNewswire/ -- The Global Thermal Barrier Coatings Market is projected to reach USD 25.82 billion in 2027. Increasing demand in the coming years is anticipated to have a positive effect on the market growth of advanced thermal barrier coatings from many end-use industries, including power, automotive, and aerospace industries. NEW YORK,Oct. 27, 2020/PRNewswire/ -- The Global Thermal Barrier Coatings Market is projected to reachUSD 25.82 billionin 2027...
PR Newswire
27/10/2020

Smart Polymers Market to Garner $9.9 Billion, Globally, By 2027 at 12.1% CAGR…

Drivers, restraints, and opportunities Drivers, restraints, and opportunities Rise in need of efficient and economical drug delivery systems, property of reversible phase transitions, and innovative use in the automobile industry have boosted the growth of the global smart polymers market. However, high cost of smart polymers hampers the market. On the contrary, surge in awareness regarding use of smart polymers would present lucrative opportunities for the market players in the future...
PR Newswire
27/10/2020

DECISION OF SCANFIL PLC'S BOARD OF DIRECTORS ON STOCK OPTION PLAN

SCANFIL PLC STOCK EXCHANGE RELEASE 27 OCTOBER 2020 3.30 P.M. DECISION OF SCANFIL PLC'S BOARD OF DIRECTORS ON STOCK OPTION PLAN On 24 April 2019, the General Meeting of shareholders of Scanfil Plc decided to authorise the Board of Directors to decide on granting stock options rights to certain key personnel of the company and its subsidiaries and to decide on the terms and conditions of the option rights. The total number of option rights can be 900,000 and they entitle the...
Nasdaq GlobeNewswire
27/10/2020

High-Temperature Fibers Market To Reach USD 17.60 Billion By 2027 | CAGR of…

NEW YORK, Oct. 27, 2020 /PRNewswire/ -- The Global High-Temperature Fibers Market is forecast to reach USD 17.60 Billion by 2027, according to a new report by Reports and Data. High-temperature fibers are in high demand due to their excellent weight-bearing capacity and thermal and flame resistance. High-temperature fibers find widespread applications in defense & safety, aerospace, automobile, manufacturing, and electrical & electronics, among other sectors. NEW YORK,Oct. 27, 2020...
PR Newswire
27/10/2020

Fineqia Invests in Blockchain Fund IDEO Colab Ventures

"Combining design and technology is the specialty of a select few but the pleasure of the very many," said Fineqia's CEO Bundeep Singh Rangar. "Our investment is to support this thesis and propagate it via IDEO CoLab Ventures." "Combining design and technology is the specialty of a select few but the pleasure of the very many," said Fineqia's CEO Bundeep Singh Rangar. "Our investment is to support this thesis and propagate it via IDEO CoLab Ventures." IDEO…
PR Newswire
27/10/2020

Signify shareholders appoint Francisco Javier van Engelen Sousa to Board of…

Press ReleaseOctober 27, 2020 Signify shareholders appoint Francisco Javier van Engelen Sousa to Board of ManagementEindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced that the Extraordinary General Meeting of Shareholders (EGM) appointed Francisco Javier van Engelen Sousa as a member of the Board of Management, effective October 27, 2020. The appointment was the only agenda item at the EGM. Javier van Engelen will fulfill the...
Nasdaq GlobeNewswire
27/10/2020

Oncolytics Biotech® Collaborates with Roche and AIO to Initiate a Phase 1/2…

Study builds on prior early findings of greater than 90% clinical benefit in colorectal and greater than 80% increase in progression-free survival in pancreatic cancer patients Study builds on prior early findings of greater than 90% clinical benefit in colorectal and greater than 80% increase in progression-free survival in pancreatic cancer patients SAN DIEGO, CAandCALGARY, AB,Oct. 27, 2020/PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced a...
PR Newswire
27/10/2020

Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001…

GEN-001 is an oral microbiome therapeutic candidate of Genome & Company. In this clinical trial, it will be administered to cancer patients by combining an immune checkpoint inhibitor for the first time among Asian microbiome development companies. GEN-001 is an oral microbiome therapeutic candidate of Genome & Company. In this clinical trial, it will be administered to cancer patients by combining an immune checkpoint inhibitor for the first time among Asian microbiome development...
PR Newswire
27/10/2020

Demand recovery in China, market conditions still weak : Elkem

"Elkem's strong competitive position has been demonstrated in weak markets and all plants have been in regular operation. Elkem had strong sales in the third quarter and all divisions reported higher volumes compared to the corresponding quarter last year. However, the result was negatively impacted by weak market conditions due to Covid-19," says Elkem's CEO, Michael Koenig. "Elkem's strong competitive position has been demonstrated in weak markets and all plants have been in…
PR Newswire
27/10/2020
Altri  Comunicati